SCHEMBL2295689

SCHEMBL2295689

Cc1ccc(C[CH]Cc2cccc3ccccc23)c(C)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 5/20 0.46
CYP3A4 P08684 3/20 0.46
CYP1A2 P05177 6/20 0.43
CYP2A6 P11509 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2D6 P10635 2/20 0.41
GRIN2B Q13224 1/20 0.40
ALDH1A1 P00352 2/20 0.40
NR3C1 P04150 1/20 0.40
PGR P06401 1/20 0.40
NR3C2 P08235 1/20 0.40
F12 P00748 1/20 0.39
IDH1 O75874 1/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5830944 0.81 CYP2C19 (0.56) CYP2C19CYP3A4CYP1A2CYP2A6MEN1
SCHEMBL5252496 0.74 CYP2C19 (0.50) CYP2C19CYP3A4CYP1A2CYP2C9CYP2D6
SCHEMBL652140 0.73 TDP1 (0.47) CYP2C19CYP1A2CYP2C9CYP2D6ALDH1A1
SCHEMBL23527419 0.71 CYP2C19 (0.55) CYP2C19CYP3A4CYP1A2CYP2A6MEN1
SCHEMBL18242791 0.71 CYP2C19 (0.47) CYP2C19CYP3A4CYP1A2MEN1KMT2A
SCHEMBL5551802 0.71 MC5R (0.58) CYP2C19CYP3A4CYP1A2CYP2A6MEN1
SCHEMBL10389881 0.70 TDP1 (0.53) CYP2C19CYP1A2MEN1KMT2ACYP2C9
SCHEMBL10390339 0.70 CYP2C19 (0.55) CYP2C19CYP3A4CYP1A2MEN1KMT2A
SCHEMBL66917 0.70 CYP2C19 (0.53) CYP2C19CYP3A4CYP1A2CYP2A6MEN1
SCHEMBL15249122 0.70 NPC1 (0.48) CYP2C19CYP3A4CYP1A2CYP2A6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011100769-A2 KINASE MODULATORS FOR THE TREATMENT OF CANCER SYNOVO GMBH (DE) 2011-08-18 WO claimed
WO-2011100769-A2 KINASE MODULATORS FOR THE TREATMENT OF CANCER SYNOVO GMBH (DE) 2011-08-18 WO disclosed